The Core will provide necessary support for the creation, selection, characterization, production, and purification of recombinant adenoviruses, as well as the isolation and culture of neonatal rat cardiomyocytes and neonatal and adult mouse cardiomyocytes. The Core is currently used by all of the Projects. The Core facility is and will be directed by Christopher Baines, Ph.D., who was appointed to the faculty in the Department of Pediatrics in 2005, Division of Molecular Cardiovascular Biology. Dr. Baines has extensive experience in cardiomyocyte preparation and in the generation and use of recombinant adenoviral vectors in the study of myocardial cell biology (Baines et al, 2005). He assumed oversight of Core operations in 2005 when Dr. Orlando Bueno left. The necessary personnel are already working in the laboratory and are fully trained. Core C will provide a variety of support services including: a. Production of the shuttle vector plasmid DNA (for distribution to investigators) b. Electroporation of transgene shuttle vector into adenoviral genomic DNA-containing bacteria for recombination c. Identification and purification of positive adenoviral recombinants d. Maintenance of human embryonic kidney (HEK) 293 cells permissive for adenoviral replication e. Amplification of recombinant cultures f. Purification and concentration of recombinant adenoviruses g. Titration of stocks for determination of plaque forming unit (pfu) levels h. Repository service for storage and cataloging of low passage viral stocks to serve as a backup for viral stocks given to investigators i. Weekly preparation of neonatal rat cardiomyocyte cultures j. Preparation of neonatal and adult mouse cardiomyocyte cultures when required

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL069779-10
Application #
8374766
Study Section
Special Emphasis Panel (ZHL1-PPG-D)
Project Start
Project End
2013-08-31
Budget Start
2012-01-01
Budget End
2012-12-31
Support Year
10
Fiscal Year
2012
Total Cost
$160,949
Indirect Cost
$53,650
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Lowey, Susan; Bretton, Vera; Joel, Peteranne B et al. (2018) Hypertrophic cardiomyopathy R403Q mutation in rabbit ?-myosin reduces contractile function at the molecular and myofibrillar levels. Proc Natl Acad Sci U S A 115:11238-11243
Valiente-Alandi, Iñigo; Potter, Sarah J; Salvador, Ane M et al. (2018) Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure. Circulation 138:1236-1252
Meng, Qinghang; Bhandary, Bidur; Bhuiyan, Md Shenuarin et al. (2018) Myofibroblast-Specific TGF? Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy. Circ Res 123:1285-1297
Singh, Sonia R; Robbins, Jeffrey (2018) Desmin and Cardiac Disease: An Unfolding Story. Circ Res 122:1324-1326
Khalil, Hadi; Maillet, Marjorie; Molkentin, Jeffery D (2017) Spatial Gene Profiling in the Ischemic Heart: Fibroblasts Put on Their SOX. Circulation 136:1410-1411
Robbins, Jeffrey (2017) Oliver Smithies, DPhil: 1925-2017. Circ Res 120:1535-1536
Tallquist, Michelle D; Molkentin, Jeffery D (2017) Redefining the identity of cardiac fibroblasts. Nat Rev Cardiol 14:484-491
Travers, Joshua G; Kamal, Fadia A; Valiente-Alandi, Iñigo et al. (2017) Pharmacological and Activated Fibroblast Targeting of G??-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression. J Am Coll Cardiol 70:958-971
Schafer, Allison E; Blaxall, Burns C (2017) G Protein Coupled Receptor-mediated Transactivation of Extracellular Proteases. J Cardiovasc Pharmacol 70:10-15
Singh, Sonia R; Zech, Antonia T L; Geertz, Birgit et al. (2017) Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3-Targeted Knockin Mice. Circ Heart Fail 10:

Showing the most recent 10 out of 131 publications